A 60‑year‑old woman with a one‑week history of six loose non‑bloody stools daily, lower abdominal cramping, recent antibiotic treatment for a urinary tract infection, tachycardia, mild diffuse abdominal tenderness, leukocytosis, elevated erythrocyte sedimentation rate and C‑reactive protein, and impaired renal function—what is the most likely diagnosis: antibiotic‑associated (chemical) colitis, inflammatory colitis, microscopic colitis, or Clostridioides difficile colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clostridioides difficile Colitis

The most likely diagnosis is Clostridioides difficile colitis (option D). This 60-year-old woman presents with the classic triad: recent antibiotic exposure for a urinary tract infection, frequent watery diarrhea (six episodes daily), and systemic inflammatory markers (leukocytosis with WBC 13,000, elevated CRP). 1

Clinical Reasoning

Key Diagnostic Features Supporting C. difficile Infection

Recent antibiotic exposure is the single most important risk factor. The patient's recent UTI treatment disrupted her normal colonic microbiota, allowing C. difficile to proliferate and produce toxins. 1 Antibiotics increase CDI risk up to sixfold during therapy and in the subsequent month. 1

The clinical presentation is characteristic:

  • Watery, non-bloody diarrhea (≥3 unformed stools per 24 hours meets diagnostic criteria) 1
  • Lower abdominal cramping (consistent with colonic inflammation) 1
  • Systemic inflammatory response with leukocytosis (13,000) and elevated CRP 1
  • Tachycardia (pulse 100/min, suggesting volume depletion or systemic inflammation) 1

Additional risk factors present:

  • Age 60 years (older age increases CDI risk) 1
  • Methotrexate use (immunosuppression increases CDI risk) 1
  • Elevated creatinine 1.5 (chronic kidney disease is an associated risk factor) 1

Why Not the Other Options?

Microscopic colitis (option C) is less likely despite some overlapping features. While microscopic colitis does present with chronic watery non-bloody diarrhea and can occur in this age group, several key differences argue against it: 2, 3, 4

  • Microscopic colitis typically has a more insidious onset over weeks to months, not the acute one-week presentation described here 3, 4
  • The marked systemic inflammatory response (leukocytosis 13,000, elevated CRP) is not characteristic of microscopic colitis, which shows normal or near-normal inflammatory markers 2, 3
  • Recent antibiotic exposure strongly points toward C. difficile rather than microscopic colitis 1
  • The acute renal impairment (creatinine 1.5) suggests volume depletion from severe diarrhea, more consistent with infectious colitis 1

"Antibiotic-associated (chemical) colitis" (option A) is not a distinct diagnostic entity. This term historically referred to benign antibiotic-associated diarrhea, but when symptoms are this severe with systemic inflammation, C. difficile must be ruled out first. 5, 6, 7

"Inflammatory colitis" (option B) is too vague and non-specific. While C. difficile does cause inflammatory colitis, this term alone doesn't represent a specific diagnosis. If this refers to inflammatory bowel disease (IBD), the acute presentation following antibiotic use makes CDI far more likely than new-onset IBD. 3

Diagnostic Approach

Immediate stool testing is mandatory:

  • Stool test for C. difficile toxin or toxigenic C. difficile using either multistep algorithms with PCR or single-step PCR (sensitivity 0.68-1.00, specificity 0.92-1.00) 1
  • Only test patients with diarrhea (≥3 unformed stools in 24 hours) - testing asymptomatic patients leads to false positives from colonization 1

Do not wait for test results to initiate empirical therapy in this case. Given the strong clinical suspicion for severe CDI (leukocytosis, elevated creatinine suggesting volume depletion, systemic symptoms), empirical treatment should be started while awaiting results. 1

Critical Pitfalls to Avoid

Do not order a "test of cure" after treatment. Up to 56% of successfully treated patients continue shedding C. difficile spores for up to six weeks asymptomatically. 1

Do not repeat testing if the first test is positive and symptoms persist during appropriate treatment - this does not change management. 1

Discontinue the offending antibiotic immediately if clinically feasible, as continued antibiotic use significantly increases recurrence risk. 1

Consider CT imaging if the patient deteriorates or shows signs of severe/complicated disease (though not immediately necessary in this stable patient). CT findings would include colonic wall thickening >4mm, accordion sign, or peri-colonic stranding. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Microscopic Colitis Diagnosis and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Colitis Causes and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lymphocytic Colitis and Inflammatory Bowel Disease Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Antibiotic-associated pseudomembranous colitis.

Reviews of infectious diseases, 1979

Related Questions

Why are oral antibiotics, such as vancomycin (Vancomycin), preferred for treating pseudomembranous colitis caused by Clostridioides difficile (C. difficile) in elderly or immunocompromised patients?
What causes pseudomembranous colitis?
What treatment options are available for a patient with colitis who is allergic to Penicillin (PCN)?
What are the recommended antibiotics (Abx) for infectious colitis?
What is the optimal treatment for an adult with pseudomembranous colitis (inflammation of the colon) caused by Clostridioides difficile (C. difficile) infection, presenting with diarrhea, abdominal pain, and high fever, after long-term antibiotic use?
What is the recommended dose and safety considerations for meperidine (pethidine) in an adult without significant comorbidities?
Can you provide a sample prescription for vitamin D3 (cholecalciferol) oral solution 125 µg/mL (5,000 IU/mL) to deliver 10,000 IU daily?
Can Aventyl (nortriptyline) be used off‑label for fibromyalgia, and if so, what starting dose, titration schedule, monitoring (blood pressure, heart rate, ECG, anticholinergic effects, mood changes) and alternative therapies should be considered?
What are the treatment guidelines for an end‑stage renal disease patient presenting with an uncomplicated upper respiratory infection?
What is the optimal management, including medication adjustments and non‑pharmacologic strategies, for a 50‑year‑old woman with vascular dementia who is very combative and anxious while taking brexpiprazole (Rexulti) 2 mg at bedtime, a rivastigmine transdermal patch, and olanzapine (Zyprexa) 5 mg twice daily?
For a patient in whom I need to decide between chronic obstructive pulmonary disease and asthma, what are the recommended medication regimens for each diagnosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.